• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肽的基质金属蛋白酶介导的活性的选择性抑制剂。

Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities.

机构信息

Torrey Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, FL 34987, USA.

出版信息

Molecules. 2012 Nov 30;17(12):14230-48. doi: 10.3390/molecules171214230.

DOI:10.3390/molecules171214230
PMID:23201642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3678729/
Abstract

The matrix metalloproteinases (MMPs) exhibit a broad array of activities, some catalytic and some non-catalytic in nature. An overall lack of selectivity has rendered small molecule, active site targeted MMP inhibitors problematic in execution. Inhibitors that favor few or individual members of the MMP family often take advantage of interactions outside the enzyme active site. We presently focus on peptide-based MMP inhibitors and probes that do not incorporate conventional Zn²⁺ binding groups. In some cases, these inhibitors and probes function by binding only secondary binding sites (exosites), while others bind both exosites and the active site. A myriad of MMP mediated-activities beyond selective catalysis can be inhibited by peptides, particularly cell adhesion, proliferation, motility, and invasion. Selective MMP binding peptides comprise highly customizable, unique imaging agents. Areas of needed improvement for MMP targeting peptides include binding affinity and stability.

摘要

基质金属蛋白酶(MMPs)具有广泛的活性,有些具有催化性质,有些则没有。由于缺乏整体选择性,小分子、活性位点靶向 MMP 抑制剂在执行过程中存在问题。那些有利于 MMP 家族中少数或个别成员的抑制剂通常利用酶活性位点之外的相互作用。我们目前专注于不包含传统 Zn²⁺结合基团的基于肽的 MMP 抑制剂和探针。在某些情况下,这些抑制剂和探针通过仅结合次要结合位点(外显子)起作用,而其他抑制剂和探针则同时结合外显子和活性位点。肽可以抑制除选择性催化以外的多种 MMP 介导的活性,特别是细胞黏附、增殖、迁移和侵袭。选择性 MMP 结合肽构成了高度可定制的独特成像剂。需要改进的 MMP 靶向肽的领域包括结合亲和力和稳定性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c99/6268493/1408f2d36ced/molecules-17-14230-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c99/6268493/5312d5343a16/molecules-17-14230-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c99/6268493/72fb42b2176c/molecules-17-14230-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c99/6268493/1408f2d36ced/molecules-17-14230-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c99/6268493/5312d5343a16/molecules-17-14230-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c99/6268493/72fb42b2176c/molecules-17-14230-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c99/6268493/1408f2d36ced/molecules-17-14230-g004.jpg

相似文献

1
Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities.基于肽的基质金属蛋白酶介导的活性的选择性抑制剂。
Molecules. 2012 Nov 30;17(12):14230-48. doi: 10.3390/molecules171214230.
2
New strategies for targeting matrix metalloproteinases.靶向基质金属蛋白酶的新策略。
Matrix Biol. 2015 May-Jul;44-46:239-46. doi: 10.1016/j.matbio.2015.01.002. Epub 2015 Jan 14.
3
Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.异三聚体三螺旋肽过渡态类似物对基质金属蛋白酶的抑制作用
Chembiochem. 2015 May 4;16(7):1084-92. doi: 10.1002/cbic.201402716. Epub 2015 Mar 12.
4
Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases.新型靶向促血管生成基质金属蛋白酶药物的作用机制。
Front Immunol. 2019 Jun 4;10:1278. doi: 10.3389/fimmu.2019.01278. eCollection 2019.
5
Understanding the binding of inhibitors of matrix metalloproteinases by molecular docking, quantum mechanical calculations, molecular dynamics simulations, and a MMGBSA/MMBappl study.通过分子对接、量子力学计算、分子动力学模拟以及MMGBSA/MMBappl研究来理解基质金属蛋白酶抑制剂的结合情况。
Mol Biosyst. 2015 Apr;11(4):1041-51. doi: 10.1039/c5mb00003c.
6
Matrix metalloproteinases: fold and function of their catalytic domains.基质金属蛋白酶:其催化结构域的折叠与功能
Biochim Biophys Acta. 2010 Jan;1803(1):20-8. doi: 10.1016/j.bbamcr.2009.04.003. Epub 2009 Apr 15.
7
Validating the 1,2-Difluoro Motif As a Hybrid Bioisostere of CF and Et Using Matrix Metalloproteinases As Structural Probes.利用基质金属蛋白酶作为结构探针验证 1,2-二氟基作为 CF 和 Et 的杂合生物等排体。
J Med Chem. 2020 Jun 11;63(11):6225-6237. doi: 10.1021/acs.jmedchem.0c00648. Epub 2020 May 22.
8
Rational design of tropoelastin peptide-based inhibitors of metalloproteinases.
Arch Biochem Biophys. 2003 Jan 15;409(2):335-40. doi: 10.1016/s0003-9861(02)00612-4.
9
Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.基质金属蛋白酶抑制剂的潜在临床应用及其未来前景。
Int J Biol Markers. 2013 Jun 28;28(2):117-30. doi: 10.5301/jbm.5000026.
10
Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.基质金属蛋白酶在癌症增殖、转移和药物靶向治疗中的作用。
Mol Biol Rep. 2021 Sep;48(9):6525-6538. doi: 10.1007/s11033-021-06635-z. Epub 2021 Aug 11.

引用本文的文献

1
Computational analysis of antimicrobial peptides targeting key receptors in infection-related cardiovascular diseases: molecular docking and dynamics insights.针对感染相关心血管疾病关键受体的抗菌肽的计算分析:分子对接与动力学见解
Sci Rep. 2025 Mar 14;15(1):8896. doi: 10.1038/s41598-025-93683-1.
2
Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer Therapy.靶向侵袭:基质金属蛋白酶-2和基质金属蛋白酶-9抑制在结直肠癌治疗中的作用
Biomolecules. 2024 Dec 30;15(1):35. doi: 10.3390/biom15010035.
3
Harnessing synergistic effects of MMP-2 Inhibition and bFGF to simultaneously preserve and vascularize cardiac extracellular matrix after myocardial infarction.

本文引用的文献

1
A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.基质金属蛋白酶-9(MMP-9)的血红素结合蛋白结构域中的一个 17 残基序列结合 α4β1 整合素,并抑制 MMP-9 在慢性淋巴细胞白血病 B 细胞中诱导的功能。
J Biol Chem. 2012 Aug 10;287(33):27601-13. doi: 10.1074/jbc.M112.354670. Epub 2012 Jun 22.
2
New opportunities in drug design of metalloproteinase inhibitors: combination between structure-function experimental approaches and systems biology.金属蛋白酶抑制剂药物设计的新机遇:结构-功能实验方法与系统生物学的结合。
Expert Opin Drug Discov. 2011 May;6(5):527-42. doi: 10.1517/17460441.2011.560936. Epub 2011 Apr 21.
3
利用基质金属蛋白酶-2抑制和碱性成纤维细胞生长因子的协同作用,在心肌梗死后同时保留心脏细胞外基质并使其血管化。
Acta Biomater. 2025 Jan 1;191:189-204. doi: 10.1016/j.actbio.2024.10.050. Epub 2024 Nov 12.
4
Discovery of bioactive peptides as therapeutic agents for skin wound repair.发现生物活性肽作为皮肤伤口修复的治疗剂。
J Tissue Eng. 2024 Sep 29;15:20417314241280359. doi: 10.1177/20417314241280359. eCollection 2024 Jan-Dec.
5
Short Antiangiogenic MMP-2 Peptide-Decorated Conjugated Linoleic Acid-Coated SPIONs for Targeted Paclitaxel Delivery in an A549 Cell Xenograft Mouse Tumor Model.短抗血管生成MMP-2肽修饰的共轭亚油酸包被的超顺磁性氧化铁纳米粒子用于A549细胞异种移植小鼠肿瘤模型中的靶向紫杉醇递送
ACS Omega. 2023 Dec 22;9(1):700-713. doi: 10.1021/acsomega.3c06489. eCollection 2024 Jan 9.
6
Identification of small molecule inhibitors against MMP-14 via High-Throughput screening.通过高通量筛选鉴定 MMP-14 的小分子抑制剂。
Bioorg Med Chem. 2023 May 1;85:117289. doi: 10.1016/j.bmc.2023.117289. Epub 2023 Apr 17.
7
Self-assembled peptide-paclitaxel nanoparticles for enhancing therapeutic efficacy in colorectal cancer.用于提高结直肠癌治疗效果的自组装肽-紫杉醇纳米颗粒
Front Bioeng Biotechnol. 2022 Sep 28;10:938662. doi: 10.3389/fbioe.2022.938662. eCollection 2022.
8
Identifying specific matrix metalloproteinase-2-inhibiting peptides through phage display-based subtractive screening.通过基于噬菌体展示的消减筛选鉴定特异性基质金属蛋白酶-2抑制肽。
Turk J Biol. 2021 Dec 14;45(6):674-682. doi: 10.3906/biy-2105-6. eCollection 2021.
9
Protein Components Inhibit MMP-2 and MMP-9 Gelatinolytic Activity In Vitro and In Vivo.蛋白质成分在体外和体内抑制 MMP-2 和 MMP-9 的明胶酶活性。
Int J Mol Sci. 2021 Dec 10;22(24):13286. doi: 10.3390/ijms222413286.
10
Hybrid fusion protein as a dual protease inhibitor for the healing of chronic wounds.融合蛋白作为一种双蛋白酶抑制剂用于慢性伤口的愈合。
Biotechnol Prog. 2021 Nov;37(6):e3209. doi: 10.1002/btpr.3209. Epub 2021 Sep 16.
Functional MMP-9 polymorphisms modulate plasma MMP-9 levels in multiple sclerosis patients.功能性 MMP-9 多态性调节多发性硬化症患者的血浆 MMP-9 水平。
J Neuroimmunol. 2012 Aug 15;249(1-2):56-9. doi: 10.1016/j.jneuroim.2012.04.001. Epub 2012 May 18.
4
Selection of peptide inhibitor to matrix metalloproteinase-2 using phage display and its effects on pancreatic cancer cell lines PANC-1 and CFPAC-1.利用噬菌体展示技术筛选基质金属蛋白酶-2的肽抑制剂及其对胰腺癌细胞系 PANC-1 和 CFPAC-1 的影响。
Int J Biol Sci. 2012;8(5):650-62. doi: 10.7150/ijbs.3897. Epub 2012 May 5.
5
In vitro selection of highly modified cyclic peptides that act as tight binding inhibitors.在体外筛选具有高修饰的环肽,作为紧密结合的抑制剂。
J Am Chem Soc. 2012 Jun 27;134(25):10469-77. doi: 10.1021/ja301017y. Epub 2012 Mar 29.
6
Matrix metalloproteinase inhibition therapy for vascular diseases.基质金属蛋白酶抑制治疗血管疾病。
Vascul Pharmacol. 2012 May-Jun;56(5-6):232-44. doi: 10.1016/j.vph.2012.01.007. Epub 2012 Feb 1.
7
Selective gelatinase inhibitor peptide is effective in targeting tongue carcinoma cell tumors in vivo.选择性明胶酶抑制剂肽在体内靶向舌鳞癌细胞肿瘤中是有效的。
Anticancer Res. 2011 Nov;31(11):3659-64.
8
Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17).通过靶向明胶酶 B/基质金属蛋白酶-9(MMP-9)和 TNF-α 转化酶(TACE/ADAM-17)从合成肽文库中定义肽抑制剂。
J Enzyme Inhib Med Chem. 2012 Aug;27(4):533-40. doi: 10.3109/14756366.2011.599323. Epub 2011 Aug 10.
9
Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor.β-淀粉样前体蛋白衍生抑制剂对基质金属蛋白酶-2(MMP-2)选择性抑制作用的结构基础。
J Biol Chem. 2011 Sep 23;286(38):33236-43. doi: 10.1074/jbc.M111.264176. Epub 2011 Aug 3.
10
Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.抑制基质金属蛋白酶 14(MMP-14)介导的癌细胞迁移。
J Biol Chem. 2011 Sep 23;286(38):33167-77. doi: 10.1074/jbc.M111.256644. Epub 2011 Jul 27.